Jump to content

Gilad Almogy

From Wikipedia, the free encyclopedia
Gilad Almogy
Born1966 (age 5960)
EducationHebrew University
California Institute of Technology
Known forUltima Genomics, Cogenra

Gilad Almogy is an Israeli-American tech entrepreneur. He is the founder of Ultima Genomics, a biotechnology company noted for developing a high-throughput machine that can sequence DNA for $100.[1]

Biography

[edit]

Almogy was born in Israel and was educated in Jerusalem. After finishing his elementary and high school education, he completed BSc in Mathematics and Physics at Hebrew University.[2] He then relocated to the United States, where he pursued a Ph.D. in Applied Physics at the California Institute of Technology.[2] Early on, his academic focus was quantum optics instead of biology or genetics.[3] After graduating, Almogy spent years working in the semiconductor industry, where he learned about scaling complex technologies.[4] For more than a decade, he worked at Applied Materials, where he rose from a division general manager for wafer inspection to senior vice president.[5]

Startups

[edit]

After working at Applied Materials, Almogy founded a startup solar company called Cogenra together with Vinod Khosla and Samir Kaul.[6][7] This was eventually bought by SunPower.[5]

In 2016, he launched Ultima Genomics, a startup that develops and manufactures systems for high-throughput DNA sequencing.[1] In a report, Almogy stated that he established the company with a team of biologists and chemists, who were former employees and acquaintances.[7] He also maintained a machine-learning and bioinformatics team in Israel. Ultima Genomics attracted attention after it announced it was able to develop a human genome sequencing technology for $100 compared the $500–600 cost from other biotech competitors such as Illumina, Inc.[8] This cost efficiency, according to Almogy, creates hyper-elastic growth that brings Moore's law-like dynamic to biology through the scaling of DNA reading.[9]

Almogy is also a director of SolarEdge Technologies, Inc.[10][11] He has invented at least 80 patented technologies.[12]

References

[edit]
  1. 1 2 "Genome sequencing co Ultima Genomics raises $600m". Globes. 2022-02-06. Retrieved 2026-07-08.
  2. 1 2 Lee, Allen (2022-06-08). "10 Things You Didn't Know about Gilad Almogy". Money Inc. Retrieved 2026-07-08.
  3. Albert, Helen (April 1, 2024). "In Conversation with Gilad Almogy". Inside Precision Medicine. 11 (2): 28–30 via GEN Publishing.
  4. Chowdhry, Amit (2025-07-08). "Ultima Genomics: Interview With Founder & CEO Gilad Almogy About The DNA Sequencing Solutions Company". Pulse 2.0. Retrieved 2026-07-08.
  5. 1 2 "$100 to profile your genome? Stealthy East Bay company says it can do just that". San Francisco Business Times. 2022-06-01. Retrieved 2026-07-13.
  6. News, Dana Hull | Bloomberg (2012-06-01). "Mercury News interview: Gilad Almogy, founder and CEO of Cogenra". The Mercury News. Retrieved 2026-07-08. {{cite web}}: |last= has generic name (help)
  7. 1 2 Furchgott, Roy (2022-10-12). "Can Start-Ups Significantly Lower the Cost of Gene Sequencing?". The New York Times. ISSN 0362-4331. Retrieved 2026-07-20.
  8. Shemer, Simona (2022-06-02). "Ultima Genomics Emerges From Stealth, Raises $600M". NoCamels. Retrieved 2026-07-13.
  9. "Gilad Almogy, Ultima Genomics". www.investmentreports.co (in Romanian). Retrieved 2026-07-13.
  10. Titan, Stock (2026-06-05). "SolarEdge (SEDG) director Gilad Almogy receives 2,634 RSUs as board award". www.stocktitan.net. Retrieved 2026-07-08.
  11. "Dr. Gilad Almogy". Bloomberg. Retrieved July 18, 2026.
  12. "DaVinci Cafe: AI & Virtual Cell · Luma". luma.com. Retrieved 2026-07-18.